Bill Mckenzie Email & Phone Number

Newton, Massachusetts, United States

Greater Boston

Farmington, Connecticut

Shoreline Biome’s mission is to enable the rapid and quantitative enumeration of the entire microbiome to strain level resolution, through its transformative technologies. Insights gained from microbiome research will ultimately lead to powerful bio-therapeutics and diagnostics. It’s just a matter of time, and Shoreline Biome is leading the way.

Beverly, Ma

seqWell has developed a transformative suite of library prep solutions for DNA sequencing that redefine the standards for throughput and output (effective read length) of any DNA sequencer. Their engineered molecular reagent platform allows users to process orders of magnitude more samples for any DNA sequencer with less time and cost, and retrieve long range information that resolves full-length phased DNA sequences. These improvements in productivity, accuracy, uniformity all reside within a streamlined, easily integrated workflow.

Greater Boston

Upstart is a management consultancy, enabling early stage life science tools and diagnostic product companies to achieve success by improving strategies and performance. Services include market analysis, business and financial modeling, strategic planning, commercialization plan construction, team building, M&A

Greater Boston Area

Our mission is to partner with visionary founders in early stage life science start-ups to develop, refine and co-exist in bringing transformative technologies and products to market. Our services consist of, but are not limited to, strategic business operations, strategic marketing development, persistent R&D support, capitalization and exit strategies. Upon engagement, we develop a robust validation plan and exit strategy. Then, working with company leadership, we manage to a maximum value exit.

Greater Boston Area

Member, Board of DirectorsWafergen, Inc (2014 - 2017)WaferGen, a publicly traded biotechnology company in Freemont, CA, offers innovative genomic technology solutions for single-cell analysis and clinical research in the life sciences, pharmaceutical, and clinical laboratory industries. In addition to board member responsibilities, I served on the Audit and Compensation committees.Member, Board of Directors Quad Technologies, Woburn, MA (2013 - 2015) Focused on the design and manufacture of innovative cell separation technology to isolate and purify stem cells in biological samples.

Waltham, Ma

P&L accountability for a global molecular diagnostic start up focused on Human Genetics and Pathogen Testing with a strong emphasis on emerging markets including China and India. Forged KOL partnerships in the US, Europe, Hong Kong, India and China that validated the clinical utility of the products resulting in accelerated market adoption.Spearheaded the strategic plan focusing on portfolio, market and channel expansion fortifying PerkinElmer’s leadership position in maternal fetal health globally and infectious disease diagnostics in China. Launched several game changing products providing earlier, more sensitive detection, for better patient outcomes. Annual sales grew 40% per year. Collaborated with business development on due diligence and integration of 2 acquisitions that expanded the portfolio and access to regional markets.

Waltham, Ma

Identified & prioritized regional opportunities, developed go to market strategies, assessed & integrated acquisition targetsCollaborated with business partners to identify, assess, acquire and integrate several acquisition targets. Led due diligence & integration of NTD Labs, which helped maintain the prenatal market leadership in the US market. Led the integration of Viacell, which expanded the product portfolio and sales channel access to OB/GYN’s and direct to consumer markets in the US. Established a clinical service lab model for the Indian market and collaborated with BD to acquire and integrate Surrendra Genetics Labs as a foundation for growth in India. Collaborated with BD and other business partners to develop a go to market strategy for China, participated in the assessment of local acquisition targets, and led the marketing due diligence and integration of Symbio Diagnostics, a leading Shanghai based kit maker.

Waltham, Ma 02451

Built and drove best practice processes for product management and marketing communications teams in this life science research and drug discovery business. Spearheaded the development of transformative strategic and tactical planning processes, developed tools to streamline the process, linked strategy to tactics, focused the team on key components and priorities that drove success through accountability and fact based management. • Established collaborations with key Mass Spec and Protein Immunoassay researchers at Johns Hopkins, George Mason, U. of Toronto, and U. of Texas to identify superior biomarkers for prenatal screening and preeclampsia.

Danvers, Ma

Developed strategy and directed the implementation of product plans for a $120M life science research tools business.Spearheaded the development of the nucleic acid purification business, launching a family of DNA purification products that grew to $12M in just 3 years. Established and managed several global marketing partnerships with key reagent and automation companies leveraging their products and channels to drive double digit sales growth ever year.

Bedford, Ma

P&L accountability for a global medical products & diagnostic membranes business. Built a strong international team of scientists, engineers, product marketing and sales individuals to drive the business. Negotiated and managed multi-million dollar contracts with key accounts including Abbott, Baxter, Roche, and Bayer. Championed a capital investment plan for a state of the art diagnostic membrane manufacturing facility that secured Millipore’s leadership position for highest quality membranes in the market. Drove strong double digit sales growth of diagnostic membranes for over 4 years